MGLL and Alzheimer disease: The spatiotemporal regulation of 2-AG signaling is tightly controlled by MAGL-mediated degradation and ABHD6-driven hydrolysis [67], with MAGL and ABHD6 also being observed with remarkable changes in the AD samples (Figure 11E).